Skip to main content

GLUT9 Antibody Blocking Peptide

Novus Biologicals, part of Bio-Techne | Catalog # NBP1-06565PEP

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
NBP1-06565PEP

Key Product Details

Conjugate

Unconjugated

Applications

Antibody Competition

Product Specifications

Description

A SLC2A9 antibody blocking peptide.

Application Notes

This peptide is useful as a blocking peptide for NBP1-06565. For further blocking peptide related protocol, click here.

Protein / Peptide Type

Antibody Blocking Peptide

Formulation, Preparation and Storage

NBP1-06565PEP
Formulation Peptide dissolved in dH2O. Contains no BSA.
Preservative No Preservative
Concentration 1.0 mg/ml
Shipping The product is shipped with dry ice or equivalent. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Store at -80C. Avoid freeze-thaw cycles.

Background: GLUT9

Glucose Transporter 9 (GLUT9), or SLC2A9, is a membrane transport protein that facilitates the traffic of uric acid and fructose across plasma memebranes. GLUT-9 is also thought to be responsible for maintaining glucose homeostasis in the cell. GLUT9 defects have been linked to both hyperuricemia and gout.

GLUT9 antibodies are useful tools for research on glucose, fructose, and uric acid regulation, as well as diseases such as hyperuricemia and gout.

Alternate Names

facilitated glucose transporter member 9, GLUT-9, GLUT9Glut9, GLUTX, solute carrier family 2 (facilitated glucose transporter), member 9, UAQTL2, urate voltage-driven efflux transporter 1

Gene Symbol

SLC2A9

Additional GLUT9 Products

Product Documents for GLUT9 Antibody Blocking Peptide

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for GLUT9 Antibody Blocking Peptide

This product is for research use only and is not approved for use in humans or in clinical diagnosis. This product is guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...